Difference between revisions of "User:Jwarner"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
m
Line 1: Line 1:
Jeremy L. Warner MD, MS - Section Editor, Hematologic Malignancy
+
Jeremy L. Warner MD, MS - Deputy Editor
  
I am an Assistant Professor of Medicine and Biomedical Informatics at Vanderbilt University and the [http://www.vicc.org Vanderbilt Ingram Cancer Center]. My clinical area is malignant hematology with a focus on the lymphoid malignancies. My research interests involve the use of informatics for clinical and research endeavors. You can learn more about me [http://www.vicc.org/dd/display.php?person=jeremy.warner here].
+
I am an Assistant Professor of [http://medicine.mc.vanderbilt.edu/ Medicine] and [http://medschool.vanderbilt.edu/dbmi/ Biomedical Informatics] at Vanderbilt University and the Medical Director of the [http://www.vicc.org Vanderbilt Ingram Cancer Center] Cancer Registry. I am one of the Associate Editors of the new ASCO journal [http://cci.jco.org/ ''JCO Clinical Cancer Informatics'']. My clinical area is malignant hematology with a focus on the lymphoid malignancies. My research interests involve the use of informatics for clinical and research endeavors, including the standardization of chemotherapy regimen information with an ultimate goal of enabling interoperability. You can learn more about me [http://www.vicc.org/dd/display.php?person=jeremy.warner here].

Revision as of 15:52, 6 September 2016

Jeremy L. Warner MD, MS - Deputy Editor

I am an Assistant Professor of Medicine and Biomedical Informatics at Vanderbilt University and the Medical Director of the Vanderbilt Ingram Cancer Center Cancer Registry. I am one of the Associate Editors of the new ASCO journal JCO Clinical Cancer Informatics. My clinical area is malignant hematology with a focus on the lymphoid malignancies. My research interests involve the use of informatics for clinical and research endeavors, including the standardization of chemotherapy regimen information with an ultimate goal of enabling interoperability. You can learn more about me here.